MARKET

AVXL

AVXL

Anavex Life Scie
NASDAQ
4.235
-0.115
-2.64%
Opening 09:37 02/10 EST
OPEN
4.340
PREV CLOSE
4.350
HIGH
4.350
LOW
4.235
VOLUME
67.04K
TURNOVER
--
52 WEEK HIGH
13.99
52 WEEK LOW
2.860
MARKET CAP
378.39M
P/E (TTM)
-7.7878
1D
5D
1M
3M
1Y
5Y
1D
Anavex Life Sciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co.
Dow Jones · 1h ago
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $20 Price Target
Benzinga · 1h ago
Analysts’ Top Healthcare Picks: Anavex Life Sciences (AVXL), Enanta Pharmaceuticals (ENTA)
TipRanks · 2h ago
Anavex: Negative EU Opinion Leaves Blarcamesine In Regulatory Purgatory
Seeking Alpha · 4h ago
Anavex Life Sciences Balances Cash Strength With EU Setback
TipRanks · 14h ago
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital
Dow Jones · 18h ago
Anavex Life Sciences Price Target Maintained With a $24.00/Share by D. Boral Capital
Dow Jones · 18h ago
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target
Benzinga · 19h ago
More
About AVXL
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. It has two core programs and two seed programs. ANAVEX 2-73 is being developed as an oral liquid once-daily formulation for rare diseases such as Rett syndrome as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease. ANAVEX 3-71 is a CNS-penetrable potential disease-modifying treatment for cognitive impairments. Its other candidates include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037.

Webull offers Anavex Life Sciences Corp stock information, including NASDAQ: AVXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVXL stock methods without spending real money on the virtual paper trading platform.